IHM
Iguana Healthcare Management Portfolio holdings
AUM
$133M
This Quarter Return
+4.58%
1 Year Return
+45.66%
3 Year Return
+127.07%
5 Year Return
–
10 Year Return
–
AUM
$166M
AUM Growth
+$166M
(+3.9%)
Cap. Flow
+$3.52M
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
45.01%
Holding
82
New
12
Increased
11
Reduced
21
Closed
12
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$9.02M |
| 2 |
AbbVie
ABBV
|
$4.8M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$4.65M |
| 4 |
HCA Healthcare
HCA
|
$4.51M |
| 5 |
Tenet Healthcare
THC
|
$3.99M |
Top Sells
| 1 |
Zimmer Biomet
ZBH
|
$8.04M |
| 2 |
Cigna
CI
|
$6.67M |
| 3 |
Merck
MRK
|
$3.33M |
| 4 |
Pfizer
PFE
|
$3.21M |
| 5 |
Incyte
INCY
|
$3.08M |
Sector Composition
| 1 | Healthcare | 87.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Biogen
BIIB
$19.4B
| $12M | 5.59% | 38,000 -6,000 | -14% | -$1.89M |
|
2
Amgen
AMGN
$155B
| $9.77M | 4.56% | 82,500 -21,500 | -21% | -$2.55M |
|
3
Medtronic
MDT
$119B
| $9.72M | 4.54% | 152,500 +42,500 | +39% | +$2.71M |
|
|
CELG
4
DELISTED
Celgene Corp
CELG
| $9.02M | 4.21% | +105,000 | New | +$9.02M |
|
|
5
Merck
MRK
$210B
| $8.53M | 3.98% | 147,500 -57,500 | -28% | -$3.33M |
|
6
Gilead Sciences
GILD
$140B
| $6.22M | 2.9% | 75,000 +25,000 | +50% | +$2.07M |
|
7
Viatris
VTRS
$12.3B
| $5.41M | 2.53% | 105,000 -7,500 | -7% | -$387K |
|
|
8
AbbVie
ABBV
$372B
| $4.8M | 2.24% | +85,000 | New | +$4.8M |
|
|
9
Ionis Pharmaceuticals
IONS
$6.79B
| $4.65M | 2.17% | +135,000 | New | +$4.65M |
|
|
GWPH
10
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $4.56M | 2.13% | 42,500 +17,500 | +70% | +$1.88M |
|
|
11
HCA Healthcare
HCA
$94.5B
| $4.51M | 2.1% | +80,000 | New | +$4.51M |
|
12
Alkermes
ALKS
$4.78B
| $4.28M | 2% | 85,000 -15,000 | -15% | -$755K |
|
13
Supernus Pharmaceuticals
SUPN
$2.53B
| $4.11M | 1.92% | 375,000 +275,000 | +275% | +$3.01M |
|
|
HZNP
14
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $4.04M | 1.88% | 255,000 -65,000 | -20% | -$1.03M |
|
|
15
Tenet Healthcare
THC
$16.3B
| $3.99M | 1.86% | +85,000 | New | +$3.99M |
|
|
ALXN
16
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $3.91M | 1.82% | 25,000 +5,000 | +25% | +$781K |
|
|
XLRN
17
DELISTED
Acceleron Pharma Inc.
XLRN
| $3.74M | 1.74% | +110,000 | New | +$3.74M |
|
|
STJ
18
DELISTED
St Jude Medical
STJ
| $3.64M | 1.7% | +52,500 | New | +$3.64M |
|
|
AERI
19
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $3.61M | 1.68% | 145,700 -64,300 | -31% | -$1.59M |
|
20
Celldex Therapeutics
CLDX
$1.47B
| $3.43M | 1.6% | 210,000 -5,000 | -2% | -$81.6K |
|
|
SLXP
21
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $3.39M | 1.58% | +27,500 | New | +$3.39M |
|
22
Ligand Pharmaceuticals
LGND
$3.15B
| $3.12M | 1.45% | 50,000 | – | – |
|
|
ELGX
23
DELISTED
Endologix Inc
ELGX
| $2.97M | 1.38% | 195,000 +2,500 | +1% | +$38K |
|
|
TRNX
24
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $2.92M | 1.36% | 125,000 -100,000 | -44% | -$2.34M |
|
|
SPNC
25
DELISTED
Spectranetics Corp
SPNC
| $2.86M | 1.33% | +125,000 | New | +$2.86M |
|